Bulk Manufacturer of Controlled Substances Application: Cambridge Isotope Laboratories, Inc., 53985-53986 [2021-21101]
Download as PDF
<![CDATA[
53985
Federal Register / Vol. 86, No. 186 / Wednesday, September 29, 2021 / Notices
Dated: September 21, 2021.
Julie H. Ernstein,
Acting Chief, National Register of Historic
Places/National Historic Landmarks Program.
[FR Doc. 2021–21103 Filed 9–28–21; 8:45 am]
BILLING CODE 4312–52–P
DEPARTMENT OF THE INTERIOR
Bureau of Reclamation
[RR04093000, XXXR4081X3,
RX.05940913.FY19310]
Glen Canyon Dam Adaptive
Management Work Group Charter
Renewal
AGENCY:
Bureau of Reclamation,
Interior.
ACTION: Notice of charter renewal.
Following consultation with
the General Services Administration,
notice is hereby given that the Secretary
of the Interior (Secretary) is renewing
the charter for the Glen Canyon Dam
Adaptive Management Work Group. The
purpose of the Adaptive Management
Work Group is to provide advice and
recommendations to the Secretary
concerning the operation of Glen
Canyon Dam and the exercise of other
authorities pursuant to applicable
Federal law.
FOR FURTHER INFORMATION CONTACT: Ms.
Lee Traynham, (801) 524–3752,
ltraynham@usbr.gov.
SUPPLEMENTARY INFORMATION: This
notice is published in accordance with
Section 9(a)(2) of the Federal Advisory
Committee Act of 1972 (Pub. L. 92–463,
as amended). The certification of
renewal is published below.
SUMMARY:
I hereby certify that Charter renewal
of the Glen Canyon Dam Adaptive
Management Work Group is in the
public interest in connection with the
performance of duties imposed on the
Department of the Interior.
Authority: 5 U.S.C. appendix 2.
Deb Haaland,
Secretary of the Interior.
[FR Doc. 2021–21145 Filed 9–28–21; 8:45 am]
BILLING CODE 4332–90–P
lotter on DSK11XQN23PROD with NOTICES1
The Advisory Committee on
Criminal Rules will hold a meeting in
Washington, DC on November 4, 2021
rather than in San Diego as previously
announced. The meeting is open to the
public for observation but not
participation. An agenda and supporting
materials will be posted at least 7 days
in advance of the meeting at: https://
www.uscourts.gov/rules-policies/
records-and-archives-rules-committees/
agenda-books. The announcement for
this meeting was previously published
in the Federal Register on June 28,
2021.
DATES: November 4, 2021.
FOR FURTHER INFORMATION CONTACT:
Scott Myers, Esq., Acting Chief Counsel,
Rules Committee Staff, Administrative
Office of the U.S. Courts, Thurgood
Marshall Federal Judiciary Building,
One Columbus Circle NE, Suite 7–300,
Washington, DC 20544, Phone (202)
502–1820, RulesCommittee_Secretary@
ao.uscourts.gov.
SUMMARY:
Dated: September 23, 2021.
Shelly L. Cox,
Management Analyst, Rules Committee Staff.
[FR Doc. 2021–21073 Filed 9–28–21; 8:45 am]
BILLING CODE 2210–55–P
JUDICIAL CONFERENCE OF THE
UNITED STATES
Advisory Committee on Evidence
Rules; Meeting of the Judicial
Conference
Judicial Conference of the
United States.
ACTION: Advisory Committee on
Evidence Rules; revised notice of open
meeting.
JUDICIAL CONFERENCE OF THE
UNITED STATES
Advisory Committee on Criminal
Rules; Meeting of the Judicial
Conference
Judicial Conference of the
United States.
AGENCY:
18:22 Sep 28, 2021
Jkt 253001
The Advisory Committee on
Evidence Rules will hold a meeting in
Washington, DC on November 5, 2021
rather than in San Diego as previously
announced. The meeting is open to the
public for observation but not
participation. An agenda and supporting
materials will be posted at least 7 days
in advance of the meeting at: https://
www.uscourts.gov/rules-policies/
records-and-archives-rules-committees/
agenda-books. The announcement for
this meeting was previously published
in the Federal Register on June 28,
2021.
DATES: November 5, 2021.
FOR FURTHER INFORMATION CONTACT:
Scott Myers, Esq., Acting Chief Counsel,
SUMMARY:
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
Rules Committee Staff, Administrative
Office of the U.S. Courts, Thurgood
Marshall Federal Judiciary Building,
One Columbus Circle NE, Suite 7–300,
Washington, DC 20544, Phone (202)
502–1820, RulesCommittee_Secretary@
ao.uscourts.gov.
(Authority: 28 U.S.C. 2073.)
Dated: September 23, 2021.
Shelly L. Cox,
Management Analyst, Rules Committee Staff.
[FR Doc. 2021–21064 Filed 9–28–21; 8:45 am]
BILLING CODE 2210–55–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–902]
Bulk Manufacturer of Controlled
Substances Application: Cambridge
Isotope Laboratories, Inc.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Cambridge Isotope
Laboratories, Inc., has applied to be
registered as a bulk manufacturer of
basic class(es) of controlled
substance(s). Refer to SUPPLEMENTAL
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before November 29, 2021. Such
persons may also file a written request
for a hearing on the application on or
before November 29, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUMMARY:
(Authority: 28 U.S.C. 2073)
AGENCY:
Certification
VerDate Sep<11>2014
Advisory Committee on
Criminal Rules; revised notice of open
meeting.
ACTION:
In
accordance with 21 CFR 1301.33(a), this
is notice that on July 29, 2021,
Cambridge Isotope Laboratories, Inc., 50
Frontage Drive, Andover, Massachusetts
01810–5413, applied to be registered as
a bulk manufacturer of the following
basic class(es) of controlled
substance(s):
SUPPLEMENTARY INFORMATION:
Drug
code
Controlled substance
Tetrahydrocannabinols ..
I
7370
Schedule
II
The company plans to synthetically
bulk manufacture the controlled
E:\FR\FM\29SEN1.SGM
29SEN1
53986
Federal Register / Vol. 86, No. 186 / Wednesday, September 29, 2021 / Notices
substance Tetrahydrocannabinols to
produce analytical standards for
distribution to its customers. No other
activity for this drug code is authorized
for this registration.
(1) Automatic Notification of Corrections to
Fingerprint Submissions
(2) National Fingerprint File Implementation:
2021 Lessons Learned
(3) Update on Policy Options for Cite and
Release Events
Brian S. Besser,
Acting Assistant Administrator.
The meeting will be conducted
virtually due to COVID–19. The public
may participate in a listen-only mode
with registration via email to AGMU@
leo.gov. Individuals must provide their
name, agency, city, state, phone, and
email address. Information regarding the
phone access link will be provided prior
to the meeting to all registered
individuals.
Any member of the public wishing to
file a written statement with the Council
or wishing to address this session of the
Council should notify the FBI Compact
Officer, Mrs. Chasity S. Anderson at
compactoffice@fbi.gov, at least 7 days
prior to the start of the session. The
notification should contain the
individual’s name and corporate
designation, consumer affiliation, or
government designation, along with a
short statement describing the topic to
be addressed and the time needed for
the presentation. Individuals will
ordinarily be allowed up to 15 minutes
to present a topic. The FBI Compact
Officer will compile all requests and
submit to the Compact Council for
consideration.
Individuals requiring special
accommodations should contact Ms.
Anderson at compactoffice@fbi.gov by
no later than October 20, 2021. Please
note all personal registration
information may be made publicly
available through a Freedom of
Information Act request.
[FR Doc. 2021–21101 Filed 9–28–21; 8:45 am]
BILLING CODE;P
DEPARTMENT OF JUSTICE
Federal Bureau of Investigation
Meeting of the Compact Council for the
National Crime Prevention and Privacy
Compact
Federal Bureau of
Investigation, Department of Justice.
ACTION: Meeting notice.
AGENCY:
The purpose of this notice is
to announce a meeting of the National
Crime Prevention and Privacy Compact
Council (Council) created by the
National Crime Prevention and Privacy
Compact Act of 1998 (Compact).
DATES: The Council will meet virtually
due to COVID–19 from 1:00 p.m. (EDT)
until 6:00 p.m. (EDT) on November 3,
2021.
ADDRESSES: Due to COVID–19 the
meeting will be held virtually. The
public will be permitted to provide
comments and/or questions related to
matters of the Council prior to the
meeting and participate in a listen-only
mode upon prior registration. Please see
details in the supplemental information.
FOR FURTHER INFORMATION CONTACT:
Inquiries may be addressed to Mrs.
Chasity S. Anderson, FBI Compact
Officer, Biometric Technology Center,
1000 Custer Hollow Road, Clarksburg,
West Virginia 26306, telephone 304–
625–2803.
SUPPLEMENTARY INFORMATION: Thus far,
the Federal Government and 34 states
are parties to the Compact which
governs the exchange of criminal history
records for licensing, employment,
immigration and naturalization matters,
and similar purposes. The Compact also
provides a legal framework for the
establishment of a cooperative federalstate system to exchange such records.
The United States Attorney General
appointed 15 persons from state and
federal agencies to serve on the Council.
The Council will prescribe system rules
and procedures for the effective and
proper operation of the Interstate
Identification Index system for
noncriminal justice purposes.
Matters for discussion are expected to
include:
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
18:22 Sep 28, 2021
Jkt 253001
Chasity S. Anderson,
FBI Compact Officer, Criminal Justice
Information Services Division, Federal Bureau
of Investigation.
[FR Doc. 2021–21170 Filed 9–28–21; 8:45 am]
BILLING CODE 4410–02–P
IV. Next Steps
V. Adjournment
CONTACT PERSON FOR MORE INFORMATION:
Lakeyia Thompson, Special Assistant,
(202) 524–9940; lthompson@nw.org.
Lakeyia Thompson,
Special Assistant.
[FR Doc. 2021–21308 Filed 9–27–21; 4:15 pm]
BILLING CODE 7570–02–P
NUCLEAR REGULATORY
COMMISSION
[Docket Nos. 50–335 and 50–389; NRC–
2021–0167]
Florida Power & Light Company;
NextEra Energy; St. Lucie Plant, Units
Nos. 1 and 2
Nuclear Regulatory
Commission.
ACTION: Subsequent license renewal
application; opportunity to request a
hearing and to petition for leave to
intervene; order imposing procedures.
AGENCY:
The U.S. Nuclear Regulatory
Commission (NRC) is considering an
application for the subsequent license
renewal of Renewed Facility Operating
License Nos. DPR–67 and NPF–16,
which authorize Florida Power & Light
Company (FPL or the applicant) to
operate St. Lucie Plant (St. Lucie), Unit
Nos. 1 and 2. The subsequent renewed
operating licenses would authorize the
applicant to operate St. Lucie for an
additional 20 years beyond the period
specified in each of the current renewed
licenses. The current renewed operating
licenses for St. Lucie expire as follows:
Unit 1 on March 1, 2036, and Unit 2 on
April 6, 2043. Because this application
contains sensitive unclassified nonsafeguards information (SUNSI), an
order imposes procedures to obtain
access to SUNSI for contention
preparation.
SUMMARY:
A request for a hearing or
petition
for leave to intervene must be
NEIGHBORHOOD REINVESTMENT
filed by November 29, 2021. Any
CORPORATION
potential party as defined in section 2.4
of title 10 of the Code of Federal
Sunshine Act Meetings
Regulations (10 CFR) who believes
TIME AND DATE: 4:00 p.m., Tuesday,
access to SUNSI is necessary to respond
October 5, 2021.
to this notice must request document
access by October 12, 2021.
PLACE: Via conference call.
STATUS: This meeting will be open to the ADDRESSES: Please refer to Docket ID
NRC–2021–0167 when contacting the
public.
NRC about the availability of
MATTERS TO BE CONSIDERED: Special
information regarding this document.
Board of Directors meeting.
You may obtain publicly available
Agenda
information related to this document
using any of the following methods:
I. Call to Order
• Federal Rulemaking Website: Go to
II. Strategic Plan Recap
https://www.regulations.gov and search
III. Discussion
PO 00000
DATES:
Frm 00045
Fmt 4703
Sfmt 4703
E:\FR\FM\29SEN1.SGM
29SEN1
]]>Agencies
[Federal Register Volume 86, Number 186 (Wednesday, September 29, 2021)]
[Notices]
[Pages 53985-53986]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-21101]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-902]
Bulk Manufacturer of Controlled Substances Application: Cambridge
Isotope Laboratories, Inc.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Cambridge Isotope Laboratories, Inc., has applied to be
registered as a bulk manufacturer of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTAL INFORMATION listed below for
further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before November 29,
2021. Such persons may also file a written request for a hearing on the
application on or before November 29, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on July 29, 2021, Cambridge Isotope Laboratories, Inc.,
50 Frontage Drive, Andover, Massachusetts 01810-5413, applied to be
registered as a bulk manufacturer of the following basic class(es) of
controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols.................. 7370 I
------------------------------------------------------------------------
The company plans to synthetically bulk manufacture the controlled
[[Page 53986]]
substance Tetrahydrocannabinols to produce analytical standards for
distribution to its customers. No other activity for this drug code is
authorized for this registration.
Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021-21101 Filed 9-28-21; 8:45 am]
BILLING CODE;P
